---
schema_version: "secwatch.filing_event.v1"
accession: "0001127537-24-000012"
form_type: "8-K"
ticker: "LUNG"
cik: "0001127537"
company_name: "Pulmonx Corp"
filed_at: "2024-02-21T23:59:59+00:00"
generated_at: "2026-06-05T21:42:02.858596+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Pulmonx CEO Glen French retires; Steve Williamson appointed President and CEO effective March 15, 2024

## Summary
- Glen French resigns as CEO effective March 15; will serve as Senior Advisor until May 1, then remain on Board.
- Steve Williamson named CEO and Board member; previously Chief Commercial Officer at Outset Medical.
- Williamson receives $580k base salary, 75% target bonus, and equity grants totaling $5M (option + RSU).
- Board reduces size to eight directors after Alissa Hsu Lynch declines re-election at 2024 annual meeting.

## SEC filing metadata
- accession: 0001127537-24-000012
- form_type: 8-K
- ticker: LUNG
- cik: 0001127537
- company_name: Pulmonx Corp
- filed_at: 2024-02-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1127537/000112753724000012/0001127537-24-000012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1127537/000112753724000012/lung-20240221.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001127537-24-000012
- JSON: https://secwatch.observer/filing/0001127537-24-000012.json
- Plain text: https://secwatch.observer/filing/0001127537-24-000012.txt

## Key facts
- Executive change
  Glendon E. French resigned as President and Chief Executive Officer at Pulmonx Corp.
  - Action: resigned
  - Role: President and Chief Executive Officer
  source text: On February 20, 2024, Glendon E. French resigned as President and Chief Executive Officer of Pulmonx Corporation (the “Company”), effective as of March 15, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1127537/000112753724000012/0001127537-24-000012-index.htm
- Executive change
  Steven S. Williamson was appointed as President and Chief Executive Officer at Pulmonx Corp.
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: On February 19, 2024, the Company’s board of directors appointed Steven S. Williamson as the Company’s President and Chief Executive Officer and a Class II member of the board of directors, each as of the Effective Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1127537/000112753724000012/0001127537-24-000012-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.